As at Feb 21, 2025, the TECH stock has a PE ratio of 64.92. This is based on the current EPS of $1 and the stock price of $64.92 per share. A decrease of 7% has been seen in the P/E ratio compared to the average of 69.6 of the last 4 quarters.
The mean historical PE ratio of BIO-TECHNE over the last ten years is 56.45. The current 64.92 PE ratio is 15% above the historical average. Over the past ten years, TECH's PE ratio was at its highest in the Jun 2021 quarter at 123.7, with a price of $112.57 and an EPS of $0.91. The Sep 2015 quarter recorded the bottom point at 32.1, with a price of $23.12 and an EPS of $0.72.
Maximum annual increase: 181.07% in 2021
Maximum annual decrease: -59.51% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 66.96 | 48.47% | $71.65 | $1.07 |
2023 | 45.1 | -9.96% | $81.63 | $1.81 |
2022 | 50.09 | -59.51% | $86.66 | $1.73 |
2021 | 123.7 | 181.07% | $112.57 | $0.91 |
2020 | 44.01 | -45.96% | $66.02 | $1.5 |
2019 | 81.44 | 84.96% | $52.12 | $0.64 |
2018 | 44.03 | -23.56% | $36.99 | $0.84 |
2017 | 57.6 | 43.03% | $29.38 | $0.51 |
2016 | 40.27 | 19.42% | $28.19 | $0.7 |
2015 | 33.72 | 9.27% | $24.62 | $0.73 |
2014 | 30.86 | 37.58% | $23.14 | $0.75 |
2013 | 22.43 | -8.11% | $17.27 | $0.77 |
2012 | 24.41 | -11.01% | $18.55 | $0.76 |
2011 | 27.43 | 41.32% | $20.84 | $0.76 |
2010 | 19.41 | -14.83% | $14.36 | $0.74 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 72.03 | -14.39% | $72.03 | $1 |
Sep 2024 | 84.14 | 25.66% | $79.93 | $0.95 |
Jun 2024 | 66.96 | 20.8% | $71.65 | $1.07 |
Mar 2024 | 55.43 | 1.3% | $70.39 | $1.27 |
Dec 2023 | 54.72 | 25.42% | $77.16 | $1.41 |
Sep 2023 | 43.63 | -3.26% | $68.07 | $1.56 |
Jun 2023 | 45.1 | 5.18% | $81.63 | $1.81 |
Mar 2023 | 42.88 | -13.6% | $74.19 | $1.73 |
Dec 2022 | 49.63 | 30.02% | $82.88 | $1.67 |
Sep 2022 | 38.17 | -23.8% | $71 | $1.86 |
Jun 2022 | 50.09 | -32.91% | $86.66 | $1.73 |
Mar 2022 | 74.66 | -22.07% | $108.26 | $1.45 |
Dec 2021 | 95.8 | -9.84% | $129.34 | $1.35 |
Sep 2021 | 106.26 | -14.1% | $121.14 | $1.14 |
Jun 2021 | 123.7 | 55.46% | $112.57 | $0.91 |
The current PE ratio of TECH is greater than its 3, 5 and 10-year historical averages.
TECH's PE ratio is lower than its peer stock QGEN, but it is greater than GE's and TMO's. BIO-TECHNE is presently trading at a higher PE ratio (64.92) than its peer group average of 35.7.
Stock name | PE ratio | Market cap |
---|---|---|
TMO Thermo Fisher Scientific Inc | 32.12 | $200.91B |
GE General Electric Co | 33.08 | $214.48B |
BDX Becton Dickinson & Co | 38.16 | $65.3B |
DHR Danaher Corp | 39.44 | $150.25B |
TECH BIO-TECHNE Corp | 64.92 | $10.26B |
QGEN Qiagen NV | 106.95 | $8.86B |
BIO Bio-Rad Laboratories Inc | N/A | $7.85B |
STEM Stem Inc | N/A | $91.87M |
ENZ Enzo Biochem Inc | N/A | $26.98M |
The price to earnings ratio for TECH stock as of Feb 21, 2025, stands at 64.92.
Over the last 3 years, the average price to earnings ratio for TECH stock is 56.45.
Over the last 5 years, the average price to earnings ratio for TECH stock is 63.68.
In the last ten years, the Jun 2021 quarter recorded the highest quarterly PE ratio at 123.7.
TECH's current price to earnings ratio is 15% above its 10-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Feb 21, 2025), BIO-TECHNE's stock price is $64.92. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $1. Therefore, BIO-TECHNE's P/E ratio for today is 64.92. PE RATIO(64.92) = STOCK PRICE($64.92) / TTM EPS($1)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.